The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...

U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on ...

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

Wolfe Research has recently initiated Pfizer Inc (PFE) stock to Underperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on October 25, 2024, Citigroup had resumed the ...

Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...

U.S. pharmaceutical giant Viatris Inc has been fined 7.58 million dirhams ($760,000) by Morocco's competition regulator for ...

Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for ...

Happenings in Boston’s life sciences ecosystem this past week include the departure of a general partner from Apple Tree Partners for another firm, Kronos Bio seeks "strategic alternatives" and new ...

A number of adults with outpatient medically attended respiratory syncytial virus (MA-RSV) infection experience ...

Meta Platforms Inc, Pfizer Inc and American Airlines are among the companies the Labor Department’s contractor watchdog has ...

The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...